Morgan Stanley’s Silence Therapeutics SLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.03M | Sell |
1,211,758
-788,347
| -39% | -$4.57M | ﹤0.01% | 3776 |
|
|
2025
Q1 | $5.64M | Buy |
2,000,105
+337,037
| +20% | +$950K | ﹤0.01% | 3826 |
|
|
2024
Q4 | $11.4M | Buy |
1,663,068
+941,651
| +131% | +$6.48M | ﹤0.01% | 3294 |
|
|
2024
Q3 | $13.1M | Buy |
721,417
+417,424
| +137% | +$7.59M | ﹤0.01% | 3213 |
|
|
2024
Q2 | $5.78M | Buy |
303,993
+61,223
| +25% | +$1.16M | ﹤0.01% | 3770 |
|
|
2024
Q1 | $5.24M | Buy |
242,770
+117,154
| +93% | +$2.53M | ﹤0.01% | 3883 |
|
|
2023
Q4 | $2.18M | Buy |
125,616
+72,319
| +136% | +$1.26M | ﹤0.01% | 4877 |
|
|
2023
Q3 | $523K | Sell |
53,297
-12,309
| -19% | -$121K | ﹤0.01% | 5146 |
|
|
2023
Q2 | $361K | Sell |
65,606
-7,071
| -10% | -$38.9K | ﹤0.01% | 5380 |
|
|
2023
Q1 | $451K | Sell |
72,677
-138,296
| -66% | -$857K | ﹤0.01% | 5315 |
|
|
2022
Q4 | $3.22M | Buy |
210,973
+55,814
| +36% | +$851K | ﹤0.01% | 4125 |
|
|
2022
Q3 | $1.56M | Buy |
155,159
+1,866
| +1% | +$18.7K | ﹤0.01% | 4601 |
|
|
2022
Q2 | $1.82M | Buy |
153,293
+1,627
| +1% | +$19.3K | ﹤0.01% | 4608 |
|
|
2022
Q1 | $2.88M | Sell |
151,666
-15,188
| -9% | -$289K | ﹤0.01% | 4236 |
|
|
2021
Q4 | $3.99M | Buy |
166,854
+156,239
| +1,472% | +$3.73M | ﹤0.01% | 3954 |
|
|
2021
Q3 | $218K | Buy |
10,615
+1,050
| +11% | +$21.6K | ﹤0.01% | 5956 |
|
|
2021
Q2 | $250K | Sell |
9,565
-553
| -5% | -$14.5K | ﹤0.01% | 5897 |
|
|
2021
Q1 | $233K | Buy |
10,118
+8,118
| +406% | +$187K | ﹤0.01% | 5572 |
|
|
2020
Q4 | $44K | Hold |
2,000
| – | – | ﹤0.01% | 6196 |
|
|
2020
Q3 | $32K | Buy |
+2,000
| New | +$32K | ﹤0.01% | 5881 |
|